Home › Kanser sa Ulo at Leeg › Missouri › St. Louis
Pag-aaral pangklinika para sa Kanser sa Ulo at Leeg sa St. Louis, MO
Isang pag-aaral para sa Kanser sa Ulo at Leeg ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa St. Louis. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Nagre-recruitPhase 2/3
- Site #0114, St Louis
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 2
- Washington University, School of Medicine, St Louis
Online Perioperative Education Program on Patient Satisfaction and Clinical Outcomes for Head and Neck Surgery
Nagre-recruit
- Washington University School of Medicine, St Louis
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Washington University, St Louis
Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT
Nagre-recruit
- Washington University in St. Louis, St Louis
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Nagre-recruitObservasyonal na pag-aaral
- Washington University School of Medicine, St Louis
IDOV-Immune for Advanced Solid Tumors
Nagre-recruitPhase 1
- Washington University School of Medicine, St Louis
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Washington University, St Louis
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Nagre-recruitPhase 1/2
- Saint Louis University, St Louis
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Nagre-recruitObservasyonal na pag-aaral
- Mercy Hospital - South, St Louis
- Mercy Hospital -STL, St Louis
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Nagre-recruitPhase 1/2
- Washington University Infusion Center Pharmacy, St Louis
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Nagre-recruitPhase 3
- GSK Investigational Site, St Louis
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Washington University School of Medicine, St Louis
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
Nagre-recruit
- Washington University in St. Louis, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, St Louis
Pag-aaral para sa Kanser sa Ulo at Leeg sa ibang lungsod
- Houston, TX30 pag-aaral
- Boston, MA22 pag-aaral
- New York City, NY21 pag-aaral
- Nashville, TN21 pag-aaral
- Dallas, TX12 pag-aaral
- Pittsburgh, PA11 pag-aaral
- San Antonio, TX10 pag-aaral
- Los Angeles, CA10 pag-aaral
- Baltimore, MD10 pag-aaral
- Washington, DC10 pag-aaral
- Durham, NC10 pag-aaral
- Chicago, IL10 pag-aaral
Iba pang pag-aaral sa St. Louis
- Non-Small Cell Lung Cancer73 pag-aaral
- Kanser sa Suso64 pag-aaral
- Metastatic Cancer54 pag-aaral
- Colorectal Cancer50 pag-aaral
- Kanser (lahat ng uri)46 pag-aaral
- Kanser sa Prostate46 pag-aaral
- Kanser sa Baga39 pag-aaral
- Kanser sa Ovary38 pag-aaral
- Kanser sa Pancreas33 pag-aaral
- Kanser ng Endometrium29 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg28 pag-aaral
- Pagkabigo ng Puso26 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.